X-Therma is competitively selected for a second US Department of Defense Phase II SBIR contract. This contract funds genitourinary organ transplants performed with XT-ViVoTM  cryopreserved tissue.


X-Therma CEO Dr. Xiaoxi Wei was an invited speaker to give an inspirational talk at Women chemists Committee (WCC) on entrepreneurship at the WCC in Chemical Enterprise Breakfast for the American Chemical Society, the world’s largest scientific society.